Debevoise Advises Clayton Dubilier & Rice in Its $250 Million Convertible Preferred Equity Investment in Covetrus

30 April 2020

Debevoise & Plimpton LLP is advising Clayton, Dubilier & Rice (“CD&R”) in its $250 million investment in Covetrus, a global leader in animal-health technology and services. For more information, please see the company’s press release

CD&R is a private investment firm with a strategy predicated on building stronger, more profitable businesses. Since inception, CD&R has managed the investment of $30 billion in 90 businesses representing a broad range of industries with an aggregate transaction value of approximately $140 billion. The firm has offices in New York and London. 

Covetrus is a global animal-health technology and services company dedicated to empowering veterinary practice partners to drive improved health and financial outcomes. It brings together products, services, and technology into a single platform that connects its customers to the solutions and insights they need to work best. 

The Debevoise team is led by M&A partner Paul Bird and includes M&A associates Spencer Gilbert, John Love and Mihai Chitulescu, capital markets partner Peter Loughran and associates Nick Pellicani and Ashtyn Ka and tax partner Peter Furci and associate David Rock.